Literature DB >> 27509029

Impact of micro-environmental changes on respiratory tract infections with intracellular bacteria.

Kensuke Shima1, Jonas Coopmeiners1, Simon Graspeuntner1, Klaus Dalhoff2, Jan Rupp1.   

Abstract

Community-acquired pneumonia is caused by intra- and extracellular bacteria, with some of these bacteria also being linked to the pathogenesis of chronic lung diseases, including asthma and chronic obstructive pulmonary disease. Chlamydia pneumoniae is an obligate intracellular pathogen that is highly sensitive to micro-environmental conditions controlling both pathogen growth and host immune responses. The availability of nutrients, as well as changes in oxygen, pH and interferon-γ levels, have been shown to directly influence the chlamydial life cycle and clearance. Although the lung has been traditionally regarded as a sterile environment, sequencing approaches have enabled the identification of a large number of bacteria in healthy and diseased lungs. The influence of the lung microbiota on respiratory infections has not been extensively studied so far and data on chlamydial infections are currently unavailable. In the present study, we speculate on how lung microbiota might interfere with acute and chronic infections by focusing exemplarily on the obligate intracellular C. pneumoniae. Furthermore, we consider changes in the gut microbiota as an additional player in the control of lung infections, especially in view the increasing evidence suggesting the involvement of the gut microbiota in various immunological processes throughout the human body.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990C. pneumoniazzm321990; COPD; SCFAs; anaerobic bacteria; chronic infection; lung; micro-environment; microbiome; respiratory tract infection

Mesh:

Year:  2016        PMID: 27509029     DOI: 10.1002/1873-3468.12353

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Differences in the lower airway microbiota of infants with and without cystic fibrosis.

Authors:  Katherine B Frayman; Kristine M Wylie; David S Armstrong; Rosemary Carzino; Stephanie D Davis; Thomas W Ferkol; Keith Grimwood; Gregory A Storch; Sarath C Ranganathan
Journal:  J Cyst Fibros       Date:  2018-12-21       Impact factor: 5.482

Review 2.  Recent developments on MOF-based platforms for antibacterial therapy.

Authors:  Yiwei Liu; Luyi Zhou; Ying Dong; Rui Wang; Ying Pan; Shuze Zhuang; Dong Liu; Jianqiang Liu
Journal:  RSC Med Chem       Date:  2021-04-09

3.  Balancing precision versus cohort transcriptomic analysis of acute and recovery phase of viral bronchiolitis.

Authors:  Ruchir Gupta; Mara L Leimanis; Marie Adams; André S Bachmann; Katie L Uhl; Caleb P Bupp; Nicholas L Hartog; Eric J Kort; Rosemary Olivero; Sarah S Comstock; Dominic J Sanfilippo; Sophia Y Lunt; Jeremy W Prokop; Surender Rajasekaran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-04-14       Impact factor: 6.011

Review 4.  Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides.

Authors:  Wilmore C Webley; David L Hahn
Journal:  Respir Res       Date:  2017-05-19

5.  Regulation of calretinin in malignant mesothelioma is mediated by septin 7 binding to the CALB2 promoter.

Authors:  Walter Blum; László Pecze; Janine Wörthmüller Rodriguez; Martine Steinauer; Beat Schwaller
Journal:  BMC Cancer       Date:  2018-04-27       Impact factor: 4.430

Review 6.  Selective pressures during chronic infection drive microbial competition and cooperation.

Authors:  Jiwasmika Baishya; Catherine A Wakeman
Journal:  NPJ Biofilms Microbiomes       Date:  2019-06-07       Impact factor: 7.290

7.  Bacterial association and comparison between lung and intestine in rats.

Authors:  Tian-Hao Liu; Chen-Yang Zhang; Ahmad Ud Din; Ning Li; Qian Wang; Jing-Ze Yu; Zhen-Yuan Xu; Chen-Xi Li; Xiao-Mei Zhang; Jia-Li Yuan; Li-Guo Chen; Zhong-Shan Yang
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

Review 8.  The Role of Innate Immunity in Pulmonary Infections.

Authors:  Huihui Zhang; Fang He; Pan Li; Philip R Hardwidge; Nengzhang Li; Yuanyi Peng
Journal:  Biomed Res Int       Date:  2021-01-22       Impact factor: 3.411

Review 9.  Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives.

Authors:  Minhua Chen; Zhangxuan Shou; Xue Jin; Yingjun Chen
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

10.  Identification of biomarkers for the accurate and sensitive diagnosis of three bacterial pneumonia pathogens using in silico approaches.

Authors:  Olalekan Olanrewaju Bakare; Marshall Keyster; Ashley Pretorius
Journal:  BMC Mol Cell Biol       Date:  2020-11-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.